Skip to main content

Dr. Jamal Hammoud, M.D.

Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)

  • Medicare participating

At a glance

Years since graduation
41
In the NPI registry since
2006
Medicare patients seen, 2024
738

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1985Medical school: Wayne State University School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Endocrinology, Diabetes & Metabolism Physician primary
    MI license JH045812

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Endocrinology & Diabetes per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
738
Services billed
4,359
Patients’ average age
70
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes824410
Established patient office or other outpatient visit, 20-29 minutes743485
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes667132
Hemoglobin a1c level, by device for home use620336
Blood glucose (sugar) level612304
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report352226
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment183161
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes154143
Ultrasound scan of head and neck soft tissue147137
New patient office or other outpatient visit, 45-59 minutes129129

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 27 companies reported 201 payments worth $41,689 in total to this clinician.

By company
Lilly USA, LLC$33,095
Boehringer Ingelheim Pharmaceuticals, Inc.$3,309
Novo Nordisk Inc$2,964
Amgen Inc.$417
Corcept Therapeutics$312
Beta Bionics, Inc.$273
Xeris Pharmaceuticals, Inc.$223
Abbott Laboratories$170
By type
Compensation for services other than consulting (speaking, faculty)$33,150
Food and Beverage$2,941
Travel and Lodging$2,809
Consulting Fee$2,790

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Feb 19, 2025Lilly USA, LLC
Feb 19, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$3,600
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 17, 2025Lilly USA, LLC
Oct 17, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 22, 2025Lilly USA, LLC
Oct 22, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Jun 13, 2025Lilly USA, LLC
Jun 13, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Apr 23, 2025Lilly USA, LLC
Apr 23, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 22, 2025Novo Nordisk Inc
Oct 22, 2025
Consulting Fee
Multiple Therapeutic Areas
$1,395
All 37 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 11, 2025Lilly USA, LLC
Dec 11, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$900
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Nov 25, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
JARDIANCE · DIABETES
$800
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
$675
Nov 19, 2025Lilly USA, LLC
Nov 19, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$900
Nov 5, 2025Lilly USA, LLC
Nov 5, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$900
Oct 30, 2025Lilly USA, LLC
Oct 30, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$900
Oct 22, 2025Lilly USA, LLC
Oct 22, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 22, 2025Novo Nordisk Inc
Oct 22, 2025
Consulting Fee
Multiple Therapeutic Areas
$1,395
Oct 22, 2025Lilly USA, LLC
Oct 22, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
$1,125
Oct 21, 2025Novo Nordisk Inc
Oct 21, 2025
Consulting Fee
Multiple Therapeutic Areas
$1,395
Oct 21, 2025Lilly USA, LLC
Oct 21, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$900
Oct 20, 2025Lilly USA, LLC
Oct 20, 2025
Travel and Lodging
travel to BAY CITY, MI · in-kind
$706
Oct 17, 2025Lilly USA, LLC
Oct 17, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 17, 2025Lilly USA, LLC
Oct 17, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
$675
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
$675
Jul 24, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jul 24, 2025
Compensation for services other than consulting (speaking, faculty)
JARDIANCE · DIABETES
$800
Jul 24, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jul 24, 2025
Compensation for services other than consulting (speaking, faculty)
JARDIANCE · DIABETES
$800
Jul 14, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jul 14, 2025
Compensation for services other than consulting (speaking, faculty)
JARDIANCE · DIABETES
$800
Jun 24, 2025Lilly USA, LLC
Jun 24, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$900
Jun 23, 2025Lilly USA, LLC
Jun 23, 2025
Travel and Lodging
MOUNJARO · Diabetes · travel to DAVISON, MI
$35.00
Jun 13, 2025Lilly USA, LLC
Jun 13, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Jun 13, 2025Lilly USA, LLC
Jun 13, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
$675
Apr 23, 2025Lilly USA, LLC
Apr 23, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,800
Apr 23, 2025Lilly USA, LLC
Apr 23, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
$1,125
Apr 17, 2025Lilly USA, LLC
Apr 17, 2025
Travel and Lodging
travel to DETROIT, MI · in-kind
$556
Mar 17, 2025Lilly USA, LLC
Mar 17, 2025
Compensation for services other than consulting (speaking, faculty)
JARDIANCE · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$800
Mar 10, 2025Lilly USA, LLC
Mar 10, 2025
Compensation for services other than consulting (speaking, faculty)
JARDIANCE · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$800
Feb 28, 2025Lilly USA, LLC
Feb 28, 2025
Travel and Lodging
MOUNJARO · Diabetes · travel to ATLANTA, GA
$55.00
Feb 19, 2025Lilly USA, LLC
Feb 19, 2025
Compensation for services other than consulting (speaking, faculty)
MOUNJARO · Diabetes
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$3,600
Feb 6, 2025Lilly USA, LLC
Feb 6, 2025
Travel and Lodging
travel to ATLANTA, GA · in-kind
$660
Feb 6, 2025Lilly USA, LLC
Feb 6, 2025
Travel and Lodging
travel to ATLANTA, MI · in-kind
$365
Feb 6, 2025Lilly USA, LLC
Feb 6, 2025
Travel and Lodging
travel to ATLANTA, MI · in-kind
$352
Feb 6, 2025Lilly USA, LLC
Feb 6, 2025
Travel and Lodging
travel to ATLANTA, MI · in-kind
$79.69

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Michigan →

Industry-funded research

Named as a principal investigator on 10 industry-funded studies in 2025, from 5 companies. The companies reported $543,571 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with establish…
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
    AbbVie Inc. · Active, not recruiting · NCT06345339
  • A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of Zibotentan/Dapagliflozin FDC Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease an…
    AstraZeneca Pharmaceuticals LP
  • A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in p…
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
    AbbVie Inc.
  • M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
    AbbVie Inc.
  • A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in p…
    Boehringer Ingelheim Pharma GmbH & Co.kg
  • A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with establish…
    Boehringer Ingelheim International GmbH
  • TA description Cardiovascular Renal and Metabolism Indications Chronic Kidney Disease Study status Ongoing Phase descripton Phase 3 Category R&D Sponsored Delivery model Internal
    AstraZeneca Pharmaceuticals LP
  • A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in p…
    Boehringer Ingelheim International GmbH

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Endocrinology & Diabetes clinicians in Flint

Sources

NPI registry (CMS NPPES, November 2026; record last updated December 14, 2018), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1639284672. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.